Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Mereo Biopharma 3 Limited”

2 pharma patents match "Mereo Biopharma 3 Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 2 pharmaceutical patents matching "Mereo Biopharma 3 Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2 results for “Mereo Biopharma 3 Limited” · 30,257 patents in full index Clear search

  1. US 12173058

    Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta

    Mereo Biopharma 3 Limited · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  2. US 10961305

    Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta

    Mereo Biopharma 3 Limited · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted